Biocon Limited
BIOCON
Rangering i aksjer
#3396
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Aksjekurs
$3.75
Sist synkronisert: 2026-10-19
Markedsverdi
$5.13B
Endring (1 dag)
-2.30%
Endring (1 år)
-9.49%
Land
IN
Handel Biocon Limited (BIOCON)
Kategori
Healthcare
Antall utestående aksjer for Biocon Limited (BIOCON)
Antall utestående aksjer per June 2026: 1.62B
Ifølge Biocon Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 1.62B. Ved slutten av March 2024 hadde selskapet 1.20B utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Biocon Limited (BIOCON) fra 2004 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 1.62B | 35.41% |
| 2025 | 1.20B | 0.15% |
| 2024 | 1.20B | 0.24% |
| 2023 | 1.19B | 0.17% |
| 2022 | 1.19B | 0.33% |
| 2021 | 1.19B | 0.25% |
| 2020 | 1.18B | 0.07% |
| 2019 | 1.18B | 0.29% |
| 2018 | 1.18B | 0.18% |
| 2017 | 1.18B | 0.00% |
| 2016 | 1.18B | -1.85% |
| 2015 | 1.20B | 1.92% |
| 2014 | 1.18B | 0.21% |
| 2013 | 1.17B | -0.04% |
| 2012 | 1.18B | 0.19% |
| 2011 | 1.17B | 0.54% |
| 2010 | 1.17B | 0.80% |
| 2009 | 1.16B | -0.13% |
| 2008 | 1.16B | -0.05% |
| 2007 | 1.16B | 1.13% |
| 2006 | 1.15B | 1.03% |
| 2005 | 1.14B | 11.70% |
| 2004 | 1.02B | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 253.90M | -84.34% |
US
|
|
| 396.00M | -75.58% |
US
|
|
| 478.91M | -70.47% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -96.17% |
NL
|
